vs
Cytek Biosciences, Inc.（CTKB）与CANTALOUPE, INC.（CTLP）财务数据对比。点击上方公司名可切换其他公司
CANTALOUPE, INC.的季度营收约是Cytek Biosciences, Inc.的1.3倍（$78.7M vs $62.1M），CANTALOUPE, INC.净利率更高（-0.1% vs -70.9%，领先70.8%），Cytek Biosciences, Inc.同比增速更快（8.1% vs 6.8%），CANTALOUPE, INC.自由现金流更多（$-614.0K vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 7.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
CTKB vs CTLP — 直观对比
营收规模更大
CTLP
是对方的1.3倍
$62.1M
营收增速更快
CTKB
高出1.3%
6.8%
净利率更高
CTLP
高出70.8%
-70.9%
自由现金流更多
CTLP
多$1.2M
$-1.8M
两年增速更快
CTKB
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $78.7M |
| 净利润 | $-44.1M | $-70.0K |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 2.0% |
| 净利率 | -70.9% | -0.1% |
| 营收同比 | 8.1% | 6.8% |
| 净利润同比 | -557.1% | -101.4% |
| 每股收益（稀释后） | — | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBCTLP
| Q4 25 | $62.1M | $78.7M | ||
| Q3 25 | $52.3M | $80.9M | ||
| Q2 25 | $45.6M | $82.6M | ||
| Q1 25 | $41.5M | $75.4M | ||
| Q4 24 | $57.5M | $73.7M | ||
| Q3 24 | $51.5M | $70.8M | ||
| Q2 24 | $46.6M | $72.7M | ||
| Q1 24 | $44.9M | $67.9M |
净利润CTKBCTLP
| Q4 25 | $-44.1M | $-70.0K | ||
| Q3 25 | $-5.5M | $-919.0K | ||
| Q2 25 | $-5.6M | $6.8M | ||
| Q1 25 | $-11.4M | $49.2M | ||
| Q4 24 | $9.6M | $5.0M | ||
| Q3 24 | $941.0K | $3.6M | ||
| Q2 24 | $-10.4M | $2.2M | ||
| Q1 24 | $-6.2M | $4.7M |
毛利率CTKBCTLP
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | 39.6% |
营业利润率CTKBCTLP
| Q4 25 | -9.0% | 2.0% | ||
| Q3 25 | -17.6% | 2.0% | ||
| Q2 25 | -23.3% | 6.3% | ||
| Q1 25 | -36.1% | 9.1% | ||
| Q4 24 | 5.2% | 8.4% | ||
| Q3 24 | -8.2% | 5.8% | ||
| Q2 24 | -18.3% | 4.9% | ||
| Q1 24 | -23.9% | 6.3% |
净利率CTKBCTLP
| Q4 25 | -70.9% | -0.1% | ||
| Q3 25 | -10.5% | -1.1% | ||
| Q2 25 | -12.2% | 8.3% | ||
| Q1 25 | -27.5% | 65.2% | ||
| Q4 24 | 16.8% | 6.7% | ||
| Q3 24 | 1.8% | 5.0% | ||
| Q2 24 | -22.4% | 3.0% | ||
| Q1 24 | -13.8% | 6.9% |
每股收益（稀释后）CTKBCTLP
| Q4 25 | — | $0.00 | ||
| Q3 25 | — | $-0.02 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.65 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.03 | ||
| Q1 24 | — | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $53.0M |
| 总债务越低越好 | — | $37.7M |
| 股东权益账面价值 | $341.7M | $252.5M |
| 总资产 | $461.5M | $381.9M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资CTKBCTLP
| Q4 25 | $90.9M | $53.0M | ||
| Q3 25 | $93.3M | $55.0M | ||
| Q2 25 | $75.5M | $51.1M | ||
| Q1 25 | $95.3M | $46.3M | ||
| Q4 24 | $98.7M | $27.7M | ||
| Q3 24 | $162.3M | $33.1M | ||
| Q2 24 | $177.9M | $58.9M | ||
| Q1 24 | $168.8M | $50.2M |
总债务CTKBCTLP
| Q4 25 | — | $37.7M | ||
| Q3 25 | — | $38.3M | ||
| Q2 25 | — | $38.7M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | $37.0M | ||
| Q3 24 | — | $37.3M | ||
| Q2 24 | — | $37.5M | ||
| Q1 24 | — | $38.1M |
股东权益CTKBCTLP
| Q4 25 | $341.7M | $252.5M | ||
| Q3 25 | $378.6M | $251.8M | ||
| Q2 25 | $377.6M | $251.0M | ||
| Q1 25 | $379.6M | $240.7M | ||
| Q4 24 | $395.7M | $190.1M | ||
| Q3 24 | $385.5M | $186.2M | ||
| Q2 24 | $389.1M | $181.7M | ||
| Q1 24 | $392.6M | $178.8M |
总资产CTKBCTLP
| Q4 25 | $461.5M | $381.9M | ||
| Q3 25 | $494.9M | $389.5M | ||
| Q2 25 | $493.3M | $381.9M | ||
| Q1 25 | $482.6M | $370.5M | ||
| Q4 24 | $499.5M | $303.0M | ||
| Q3 24 | $491.2M | $312.1M | ||
| Q2 24 | $483.7M | $335.6M | ||
| Q1 24 | $492.1M | $319.9M |
负债/权益比CTKBCTLP
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $3.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-614.0K |
| 自由现金流率自由现金流/营收 | -2.9% | -0.8% |
| 资本支出强度资本支出/营收 | 1.6% | 4.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $25.8M |
8季度趋势，按日历期对齐
经营现金流CTKBCTLP
| Q4 25 | $-771.0K | $3.1M | ||
| Q3 25 | $-3.9M | $7.0M | ||
| Q2 25 | $108.0K | $9.4M | ||
| Q1 25 | $-125.0K | $22.4M | ||
| Q4 24 | $2.0M | $522.0K | ||
| Q3 24 | $13.2M | $-12.0M | ||
| Q2 24 | $6.2M | $14.3M | ||
| Q1 24 | $4.0M | $14.7M |
自由现金流CTKBCTLP
| Q4 25 | $-1.8M | $-614.0K | ||
| Q3 25 | $-4.6M | $3.5M | ||
| Q2 25 | $-1.5M | $4.3M | ||
| Q1 25 | $-974.0K | $18.6M | ||
| Q4 24 | $1.1M | $-3.8M | ||
| Q3 24 | $12.2M | $-15.8M | ||
| Q2 24 | $5.2M | $8.5M | ||
| Q1 24 | $3.4M | $11.4M |
自由现金流率CTKBCTLP
| Q4 25 | -2.9% | -0.8% | ||
| Q3 25 | -8.7% | 4.4% | ||
| Q2 25 | -3.2% | 5.3% | ||
| Q1 25 | -2.3% | 24.6% | ||
| Q4 24 | 1.9% | -5.1% | ||
| Q3 24 | 23.7% | -22.3% | ||
| Q2 24 | 11.0% | 11.7% | ||
| Q1 24 | 7.6% | 16.9% |
资本支出强度CTKBCTLP
| Q4 25 | 1.6% | 4.8% | ||
| Q3 25 | 1.3% | 4.2% | ||
| Q2 25 | 3.5% | 6.2% | ||
| Q1 25 | 2.0% | 5.1% | ||
| Q4 24 | 1.6% | 5.8% | ||
| Q3 24 | 2.0% | 5.4% | ||
| Q2 24 | 2.3% | 7.9% | ||
| Q1 24 | 1.3% | 4.8% |
现金转化率CTKBCTLP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.38× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | 0.21× | 0.10× | ||
| Q3 24 | 14.05× | -3.36× | ||
| Q2 24 | — | 6.47× | ||
| Q1 24 | — | 3.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
